3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
24
Fallopian Tube Neoplasms
20
Breast Neoplasms
10
Carcinoma, Ovarian Epithelial
8
Sarcoma
6
Neoplasms
4
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
3
Sarcoma, Kaposi
2
Sarcoma, Ewing
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Multi-centric Castleman's Disease
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leiomyosarcoma
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
AIDS-related Kaposi sarcoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Interventions
pembrolizumab
141
Nivolumab
117
Ipilimumab
69
Cyclophosphamide
34
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
fludarabine
22
binimetinib
22
Interleukin-2
21
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
aldesleukin
16
CTLA-4 Antigen
16
fludarabine phosphate
15
cemiplimab
15
atezolizumab
15
Radiosurgery
15
Opdualag
14
Radiotherapy
11
lifileucel
10
lenvatinib
10
Blood Specimen Collection
10
spartalizumab
8
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
liposomal doxorubicin
×
1 year
×
Clear all
No trials found.